NELIX vs. BIVIX
Compare and contrast key facts about Nuveen Equity Long/Short Fund (NELIX) and Invenomic Fund Institutional Class (BIVIX).
NELIX is managed by Nuveen. It was launched on Dec 29, 2008. BIVIX is an actively managed fund by Invenomic. It was launched on Jun 19, 2017.
Performance
NELIX vs. BIVIX - Performance Comparison
Loading graphics...
NELIX vs. BIVIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NELIX Nuveen Equity Long/Short Fund | -4.35% | 11.31% | 20.55% | 24.09% | -14.94% | 32.92% | -0.79% | 6.35% | -2.36% | 13.14% |
BIVIX Invenomic Fund Institutional Class | 6.05% | 4.63% | -8.81% | 16.80% | 50.01% | 63.81% | 11.46% | 11.59% | 3.68% | 8.93% |
Returns By Period
In the year-to-date period, NELIX achieves a -4.35% return, which is significantly lower than BIVIX's 6.05% return.
NELIX
- 1D
- -0.29%
- 1M
- -4.44%
- YTD
- -4.35%
- 6M
- -3.17%
- 1Y
- 11.79%
- 3Y*
- 15.32%
- 5Y*
- 9.56%
- 10Y*
- 9.10%
BIVIX
- 1D
- 3.47%
- 1M
- 2.62%
- YTD
- 6.05%
- 6M
- 11.34%
- 1Y
- 7.17%
- 3Y*
- 1.96%
- 5Y*
- 17.01%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
NELIX vs. BIVIX - Expense Ratio Comparison
NELIX has a 1.35% expense ratio, which is lower than BIVIX's 3.17% expense ratio.
Return for Risk
NELIX vs. BIVIX — Risk / Return Rank
NELIX
BIVIX
NELIX vs. BIVIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nuveen Equity Long/Short Fund (NELIX) and Invenomic Fund Institutional Class (BIVIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NELIX | BIVIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.92 | 0.33 | +0.58 |
Sortino ratioReturn per unit of downside risk | 1.34 | 0.67 | +0.67 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.07 | +0.13 |
Calmar ratioReturn relative to maximum drawdown | 1.11 | 0.44 | +0.66 |
Martin ratioReturn relative to average drawdown | 4.90 | 0.99 | +3.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| NELIX | BIVIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.92 | 0.33 | +0.58 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.76 | 1.07 | -0.31 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.67 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.67 | 1.05 | -0.38 |
Correlation
The correlation between NELIX and BIVIX is -0.02. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Dividends
NELIX vs. BIVIX - Dividend Comparison
NELIX's dividend yield for the trailing twelve months is around 3.98%, more than BIVIX's 2.07% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NELIX Nuveen Equity Long/Short Fund | 3.98% | 3.81% | 4.78% | 4.20% | 6.84% | 2.44% | 0.00% | 0.00% | 1.35% | 1.58% |
BIVIX Invenomic Fund Institutional Class | 2.07% | 2.20% | 3.95% | 20.15% | 27.91% | 16.08% | 3.15% | 3.19% | 4.79% | 1.21% |
Drawdowns
NELIX vs. BIVIX - Drawdown Comparison
The maximum NELIX drawdown since its inception was -28.72%, which is greater than BIVIX's maximum drawdown of -18.32%. Use the drawdown chart below to compare losses from any high point for NELIX and BIVIX.
Loading graphics...
Drawdown Indicators
| NELIX | BIVIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.72% | -18.32% | -10.40% |
Max Drawdown (1Y)Largest decline over 1 year | -8.92% | -13.71% | +4.79% |
Max Drawdown (5Y)Largest decline over 5 years | -19.30% | -17.23% | -2.07% |
Max Drawdown (10Y)Largest decline over 10 years | -28.72% | — | — |
Current DrawdownCurrent decline from peak | -6.31% | -0.64% | -5.67% |
Average DrawdownAverage peak-to-trough decline | -4.75% | -5.75% | +1.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.03% | 6.10% | -4.07% |
Volatility
NELIX vs. BIVIX - Volatility Comparison
The current volatility for Nuveen Equity Long/Short Fund (NELIX) is 3.34%, while Invenomic Fund Institutional Class (BIVIX) has a volatility of 7.63%. This indicates that NELIX experiences smaller price fluctuations and is considered to be less risky than BIVIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| NELIX | BIVIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.34% | 7.63% | -4.29% |
Volatility (6M)Calculated over the trailing 6-month period | 7.26% | 16.63% | -9.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 13.50% | 20.71% | -7.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 12.67% | 16.09% | -3.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 13.71% | 16.60% | -2.89% |